Cargando…

A Potential Alternative Orodispersible Formulation to Prednisolone Sodium Phosphate Orally Disintegrating Tablets

The orally disintegrating tablet (ODT) has shown vast potential as an alternative oral dosage form to conventional tablets wherein they can disintegrate rapidly (≤30 s) upon contact with saliva fluid and should have an acceptable mouthfeel as long as their weight doesn’t exceed 500 mg. However, owin...

Descripción completa

Detalles Bibliográficos
Autores principales: Tawfik, Essam A., Scarpa, Mariagiovanna, Abdelhakim, Hend E., Bukhary, Haitham A., Craig, Duncan Q. M., Barker, Susan A., Orlu, Mine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832848/
https://www.ncbi.nlm.nih.gov/pubmed/33477855
http://dx.doi.org/10.3390/pharmaceutics13010120
_version_ 1783641926358007808
author Tawfik, Essam A.
Scarpa, Mariagiovanna
Abdelhakim, Hend E.
Bukhary, Haitham A.
Craig, Duncan Q. M.
Barker, Susan A.
Orlu, Mine
author_facet Tawfik, Essam A.
Scarpa, Mariagiovanna
Abdelhakim, Hend E.
Bukhary, Haitham A.
Craig, Duncan Q. M.
Barker, Susan A.
Orlu, Mine
author_sort Tawfik, Essam A.
collection PubMed
description The orally disintegrating tablet (ODT) has shown vast potential as an alternative oral dosage form to conventional tablets wherein they can disintegrate rapidly (≤30 s) upon contact with saliva fluid and should have an acceptable mouthfeel as long as their weight doesn’t exceed 500 mg. However, owing to the bitterness of several active ingredients, there is a need to find a suitable alternative to ODTs that maintains their features and can be taste-masked more simply and inexpensively. Therefore, electrospun nanofibers and solvent-cast oral dispersible films (ODFs) are used in this study as potential OD formulations for prednisolone sodium phosphate (PSP) that is commercially available as ODTs. The encapsulation efficiency (EE%) of the ODFs was higher (≈100%) compared to the nanofibers (≈87%), while the disintegration time was considerably faster for the electrospun nanofibers (≈30 s) than the solvent-cast ODFs (≈700 s). Hence, accelerated release rate of PSP from the nanofibers was obtained, due to their higher surface area and characteristic surface morphology that permitted higher wettability and thus, faster erosion. Taste-assessment study using the electronic-tongue quantified the bitterness threshold of the drug and its aversiveness concentration (2.79 mM). Therefore, a taste-masking strategy would be useful when further formulating PSP as an OD formulation.
format Online
Article
Text
id pubmed-7832848
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-78328482021-01-26 A Potential Alternative Orodispersible Formulation to Prednisolone Sodium Phosphate Orally Disintegrating Tablets Tawfik, Essam A. Scarpa, Mariagiovanna Abdelhakim, Hend E. Bukhary, Haitham A. Craig, Duncan Q. M. Barker, Susan A. Orlu, Mine Pharmaceutics Article The orally disintegrating tablet (ODT) has shown vast potential as an alternative oral dosage form to conventional tablets wherein they can disintegrate rapidly (≤30 s) upon contact with saliva fluid and should have an acceptable mouthfeel as long as their weight doesn’t exceed 500 mg. However, owing to the bitterness of several active ingredients, there is a need to find a suitable alternative to ODTs that maintains their features and can be taste-masked more simply and inexpensively. Therefore, electrospun nanofibers and solvent-cast oral dispersible films (ODFs) are used in this study as potential OD formulations for prednisolone sodium phosphate (PSP) that is commercially available as ODTs. The encapsulation efficiency (EE%) of the ODFs was higher (≈100%) compared to the nanofibers (≈87%), while the disintegration time was considerably faster for the electrospun nanofibers (≈30 s) than the solvent-cast ODFs (≈700 s). Hence, accelerated release rate of PSP from the nanofibers was obtained, due to their higher surface area and characteristic surface morphology that permitted higher wettability and thus, faster erosion. Taste-assessment study using the electronic-tongue quantified the bitterness threshold of the drug and its aversiveness concentration (2.79 mM). Therefore, a taste-masking strategy would be useful when further formulating PSP as an OD formulation. MDPI 2021-01-19 /pmc/articles/PMC7832848/ /pubmed/33477855 http://dx.doi.org/10.3390/pharmaceutics13010120 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Tawfik, Essam A.
Scarpa, Mariagiovanna
Abdelhakim, Hend E.
Bukhary, Haitham A.
Craig, Duncan Q. M.
Barker, Susan A.
Orlu, Mine
A Potential Alternative Orodispersible Formulation to Prednisolone Sodium Phosphate Orally Disintegrating Tablets
title A Potential Alternative Orodispersible Formulation to Prednisolone Sodium Phosphate Orally Disintegrating Tablets
title_full A Potential Alternative Orodispersible Formulation to Prednisolone Sodium Phosphate Orally Disintegrating Tablets
title_fullStr A Potential Alternative Orodispersible Formulation to Prednisolone Sodium Phosphate Orally Disintegrating Tablets
title_full_unstemmed A Potential Alternative Orodispersible Formulation to Prednisolone Sodium Phosphate Orally Disintegrating Tablets
title_short A Potential Alternative Orodispersible Formulation to Prednisolone Sodium Phosphate Orally Disintegrating Tablets
title_sort potential alternative orodispersible formulation to prednisolone sodium phosphate orally disintegrating tablets
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832848/
https://www.ncbi.nlm.nih.gov/pubmed/33477855
http://dx.doi.org/10.3390/pharmaceutics13010120
work_keys_str_mv AT tawfikessama apotentialalternativeorodispersibleformulationtoprednisolonesodiumphosphateorallydisintegratingtablets
AT scarpamariagiovanna apotentialalternativeorodispersibleformulationtoprednisolonesodiumphosphateorallydisintegratingtablets
AT abdelhakimhende apotentialalternativeorodispersibleformulationtoprednisolonesodiumphosphateorallydisintegratingtablets
AT bukharyhaithama apotentialalternativeorodispersibleformulationtoprednisolonesodiumphosphateorallydisintegratingtablets
AT craigduncanqm apotentialalternativeorodispersibleformulationtoprednisolonesodiumphosphateorallydisintegratingtablets
AT barkersusana apotentialalternativeorodispersibleformulationtoprednisolonesodiumphosphateorallydisintegratingtablets
AT orlumine apotentialalternativeorodispersibleformulationtoprednisolonesodiumphosphateorallydisintegratingtablets
AT tawfikessama potentialalternativeorodispersibleformulationtoprednisolonesodiumphosphateorallydisintegratingtablets
AT scarpamariagiovanna potentialalternativeorodispersibleformulationtoprednisolonesodiumphosphateorallydisintegratingtablets
AT abdelhakimhende potentialalternativeorodispersibleformulationtoprednisolonesodiumphosphateorallydisintegratingtablets
AT bukharyhaithama potentialalternativeorodispersibleformulationtoprednisolonesodiumphosphateorallydisintegratingtablets
AT craigduncanqm potentialalternativeorodispersibleformulationtoprednisolonesodiumphosphateorallydisintegratingtablets
AT barkersusana potentialalternativeorodispersibleformulationtoprednisolonesodiumphosphateorallydisintegratingtablets
AT orlumine potentialalternativeorodispersibleformulationtoprednisolonesodiumphosphateorallydisintegratingtablets